In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)

By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of pati...

Full description

Bibliographic Details
Main Authors: Ina Bergheim, Giridhar Kanuri
Format: Article
Language:English
Published: MDPI AG 2013-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/14/6/11963
id doaj-b0a1815ca3df46358eb5e9bd34ad4944
record_format Article
spelling doaj-b0a1815ca3df46358eb5e9bd34ad49442020-11-24T22:57:38ZengMDPI AGInternational Journal of Molecular Sciences1422-00672013-06-01146119631198010.3390/ijms140611963In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)Ina BergheimGiridhar KanuriBy now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of patients progress to end-stages of the disease, and the course of the disease progression to the later stages seems to be slow, developing progressively over several years. Key risk factors including overweight, insulin resistance, a sedentary life-style and an altered dietary pattern, as well as genetic factors and disturbances of the intestinal barrier function have been identified in recent years. Despite intense research efforts that lead to the identification of these risk factors, knowledge about disease initiation and molecular mechanisms involved in progression is still limited. This review summarizes diet-induced and genetic animal models, as well as cell culture models commonly used in recent years to add to the understanding of the mechanisms involved in NAFLD, also referring to their advantages and disadvantages.http://www.mdpi.com/1422-0067/14/6/11963animal modelsin vitro modelsnon-alcoholic fatty liver diseaseinsulin resistancediet
collection DOAJ
language English
format Article
sources DOAJ
author Ina Bergheim
Giridhar Kanuri
spellingShingle Ina Bergheim
Giridhar Kanuri
In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
International Journal of Molecular Sciences
animal models
in vitro models
non-alcoholic fatty liver disease
insulin resistance
diet
author_facet Ina Bergheim
Giridhar Kanuri
author_sort Ina Bergheim
title In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
title_short In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
title_full In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
title_fullStr In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
title_full_unstemmed In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
title_sort in vitro and in vivo models of non-alcoholic fatty liver disease (nafld)
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2013-06-01
description By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of patients progress to end-stages of the disease, and the course of the disease progression to the later stages seems to be slow, developing progressively over several years. Key risk factors including overweight, insulin resistance, a sedentary life-style and an altered dietary pattern, as well as genetic factors and disturbances of the intestinal barrier function have been identified in recent years. Despite intense research efforts that lead to the identification of these risk factors, knowledge about disease initiation and molecular mechanisms involved in progression is still limited. This review summarizes diet-induced and genetic animal models, as well as cell culture models commonly used in recent years to add to the understanding of the mechanisms involved in NAFLD, also referring to their advantages and disadvantages.
topic animal models
in vitro models
non-alcoholic fatty liver disease
insulin resistance
diet
url http://www.mdpi.com/1422-0067/14/6/11963
work_keys_str_mv AT inabergheim invitroandinvivomodelsofnonalcoholicfattyliverdiseasenafld
AT giridharkanuri invitroandinvivomodelsofnonalcoholicfattyliverdiseasenafld
_version_ 1725649936767254528